Correction to: Impact of an electronic monitoring device and behavioural feedback on adherence to multiple sclerosis therapies in youth: results of a randomized trial

from Quality of Life Research at http://bit.ly/2BBSFT3 on December 23, 2017 at 04:21AM Abstract The clinicaltrials.gov identifying number for the article titled “Impact of an electronic monitoring device and behavioral feedback on adherence to multiple sclerosis therapies in youth: results of a randomized trial” is NCT02234713 (http://bit.ly/2kZWoyA).

Healthcare Triage Podcast!

from The Incidental Economist at http://bit.ly/2piBqjE on December 22, 2017 at 09:25PM I haven’t been good about posting this, but Healthcare Triage has a podcast. Well, we’ve had one for some time, but it used to be just the audio of the live show. But now it’s a real podcast, released about every other week. […]

Psychometric evaluation of the PainCAS Interference with Daily Activities, Psychological/Emotional Distress, and Pain scales

from Quality of Life Research at http://bit.ly/2zh2jUR on December 22, 2017 at 04:21PM Abstract Purpose The PainCAS is a web-based clinical tool for assessing and tracking pain and opioid risk in chronic pain patients. Despite evidence for its utility within the clinical setting, the PainCAS scales have never been subject to psychometric evaluation. The current […]

AEA interviews: the video

from Market Design at http://bit.ly/2Bz99eC on December 22, 2017 at 01:24PM Going to the AEA to interview for a job?  Here’s a video in which various already-employed economists reflect on the process of becoming employed… Here’s the webpage: Interviewing at AEA? Watch this first.  Laughs, Scares, and Wisdom from AEAs Past!

Estimating the Reference Incremental Cost-Effectiveness Ratio for the Australian Health System

from PharmacoEconomics at http://bit.ly/2Dwr576 on December 22, 2017 at 08:15AM Abstract Background Spending on new healthcare technologies increases net population health when the benefits of a new technology are greater than their opportunity costs—the benefits of the best alternative use of the additional resources required to fund a new technology. Objective The objective of this […]

On the commensurability of efficiency

from The Academic Health Economists’ Blo… at http://bit.ly/2BN5NkZ on December 22, 2017 at 07:01AM In this week’s round-up, I highlighted a recent paper in the journal Cambridge Quarterly of Healthcare Ethics. There are some interesting ideas presented regarding the challenge of decision-making at the individual patient level, and in particular a supposed trade-off between achieving efficiency […]

Friday Links

from Healthcare Economist at http://bit.ly/2peyJQu on December 22, 2017 at 06:54AM An open-source approach to value assessment Economic freedom in North America. Cyberbullying and suicide. Why are we moving away from academic medical centers to academic health systems? Reform within state employee health plans

Friday Links

from Healthcare Economist at http://bit.ly/2peyJQu on December 22, 2017 at 06:54AM An open-source approach to value assessment Economic freedom in North America. Cyberbullying and suicide. Why are we moving away from academic medical centers to academic health systems? Reform within state employee health plans

Individual diseases or clustering of health conditions? Association between multiple chronic diseases and health-related quality of life in adults

from Health and Quality of Life Outcomes at http://bit.ly/2BYoR28 on December 21, 2017 at 04:48PM Chronic diseases are highly prevalent and cluster in individuals (multimorbidity). This study investigated the association between multimorbidity and Health-Related Quality of Life (HRQoL), assessing the combi…

Innovative drugs: Mapping the Pricing, Reimbursement and HTA Landscape

from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2kCAB0H on December 21, 2017 at 04:23PM Widespread patient access to innovative new products is being frustrated in non-U.S. markets by health technology assessments (HTA). Between January 2016 and June 2017, 58 innovative medicines were approved and launched in the U.S. — but what of their status elsewhere? […]

Australian Utility Weights for the EORTC QLU-C10D, a Multi-Attribute Utility Instrument Derived from the Cancer-Specific Quality of Life Questionnaire, EORTC QLQ-C30

from PharmacoEconomics at http://bit.ly/2CSYbgm on December 21, 2017 at 03:16PM Abstract Background The EORTC QLU-C10D is a new multi-attribute utility instrument derived from the widely used cancer-specific quality-of-life (QOL) questionnaire, EORTC QLQ-C30. The QLU-C10D contains ten dimensions (Physical, Role, Social and Emotional Functioning; Pain, Fatigue, Sleep, Appetite, Nausea, Bowel Problems), each with four levels. To […]

Professor Eva Kaltenthaler receives ScHARR’s Athena SWAN Award

from Health Economics and Decision Science Blog @ ScHARR at http://bit.ly/2z7NSTe on December 21, 2017 at 08:00AM Earlier this month HEDS Professor Eva Kaltenthaler attended the Athena SWAN Awards to accept ScHARR’s second Silver Award. The event was hosted at the University of Glasgow.Professor Kaltenthaler said: “This is a great achievement and underpins ScHARR’s commitment […]